Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282392 · ClinicalTrials.gov registry record · NA
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
A NA study of Lupus and Chronic Widespread Pain, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07282392: Recruiting NA study of Lupus and Chronic Widespread Pain, sponsored by University of Utah.
NCT07282392 is a NA study of Lupus and Chronic Widespread Pain that is actively recruiting participants, run by University of Utah. The registered enrollment target is 30 participants, below the 283-participant average among 13 other Lupus trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07282392, a NA study of Lupus and Chronic Widespread Pain, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims to answer are: Is the psychotherapy treatment safe for lupus patients? Are lupus patients able to complete the treatment? Can the treatment help improve chronic pain and other symptoms in lupus patients? Researchers will compare the treatment to a control (participants who will continue their medical treatment but will not receive psychotherapy for the time frame of the treatment) to see if the psychotherapy treatment works to relieve widespread pain and other lupus-related symptoms. Participants will: Fill out questionnaires before and after the treatment. Participate in 8 weekly treatment sessions, 2 hours per session, delivered via Zoom from their own home. Keep a list of medications and monitor any changes in their medication regimen.
Primary Outcome
A licensed rheumatologist will ask participants to identify 19 areas where they felt pain over the past week. The score ranges from 0 to 19 (the number of bodily regions).
Conditions Studied
Interventions
- BEHAVIORAL Emotional Awareness and Expression Therapy (EAET)
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2028-11-04 |
| Phase | NA |
What NCT07282392 shows while recruiting
NCT07282392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 283-participant average among 13 other Lupus trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Lupus appearing as the primary indexed condition, and to 1 intervention - of which Emotional Awareness and Expression Therapy (EAET) is the first listed.
NCT07282392 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07282392 about?
NCT07282392 is a clinical study titled "Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)". The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims to answer are: Is the psychotherapy treatment safe for lupus patients? Are lupus patients able to complete the treatment? Can the treatment...
What is the current status of trial NCT07282392?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-12-01. Estimated completion is 2028-11-04.
What conditions does trial NCT07282392 study?
This clinical trial studies the following conditions: Lupus, Chronic Widespread Pain, Fibromyalgia (FM).
What interventions are being tested in trial NCT07282392?
The interventions under investigation include: Emotional Awareness and Expression Therapy (EAET) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07282392?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07282392 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lupus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07282392's enrollment target sits among peer trials
30 10th of 13 higher than 4 of 13 other Lupus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lupus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
ACTIVE NOT RECRUITING · NA
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
RECRUITING · Phase 1
-
Safety and Efficacy of ONT01 in Lupus
RECRUITING · Early Phase 1
-
Patient-Centered Assessment of Symptoms and Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI